{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:42:06Z","timestamp":1781800926289,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00108-022-01444-3","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T16:10:58Z","timestamp":1670515858000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Parkinson-Krankheit","Parkinson\u02bcs disease"],"prefix":"10.1007","volume":"64","author":[{"given":"Tobias","family":"Warnecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Lummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Wilhelm","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"L\u00fcttje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland\u00a0D, Zaccai\u00a0J, Brayne\u00a0C (2005) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20:1255\u20131263","journal-title":"Mov Disord"},{"key":"1444_CR2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00115-019-00825-8","volume":"90","author":"K Amadori","year":"2019","unstructured":"Amadori\u00a0K, Steiner\u00a0T (2019) Parkinson\u2019s syndromes in geriatric patients : epidemiological, clinical and therapeutic characteristics. Nervenarzt 90:1279\u20131291","journal-title":"Nervenarzt"},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaneurol.2020.2412","volume":"77","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong\u00a0MJ, Okun\u00a0MS (2020) Time for a\u00a0new image of Parkinson disease. JAMA Neurol 77:1345\u20131346","journal-title":"JAMA Neurol"},{"key":"1444_CR4","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg\u00a0D, Postuma\u00a0RB, Adler\u00a0CH et\u00a0al (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30:1600\u20131611","journal-title":"Mov Disord"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1474-4422(20)30064-8","volume":"19","author":"BR Bloem","year":"2020","unstructured":"Bloem\u00a0BR, Henderson\u00a0EJ, Dorsey\u00a0ER et al (2020) Integrated and patient-centred management of Parkinson\u2019s disease: a\u00a0network model for reshaping chronic neurological care. Lancet Neurol 19:623\u2013634","journal-title":"Lancet Neurol"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem\u00a0BR, Okun\u00a0MS, Klein\u00a0C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303","journal-title":"Lancet"},{"key":"1444_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"Collaborators GBDPSD","year":"2018","unstructured":"Collaborators GBDPSD (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a\u00a0systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953","journal-title":"Lancet Neurol"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42466-019-0021-5","volume":"1","author":"R Dziewas","year":"2019","unstructured":"Dziewas\u00a0R, Auf Dem Brinke\u00a0M, Birkmann\u00a0U et al (2019) Safety and clinical impact of FEES\u2014results of the FEES-registry. Neurol Res Pract 1:16","journal-title":"Neurol Res Pract"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre\u00a0M, Aarsland\u00a0D, Brown\u00a0R et\u00a0al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707 (quiz 1837)","journal-title":"Mov Disord"},{"key":"1444_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano\u00a0A, Visanji\u00a0NP, Liu\u00a0LW et\u00a0al (2015) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 14:625\u2013639","journal-title":"Lancet Neurol"},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mdc3.12908","volume":"7","author":"J Fukae","year":"2020","unstructured":"Fukae\u00a0J, Fujioka\u00a0S, Umemoto\u00a0G et al (2020) Impact of residual drug in the pharynx on the delayed-on phenomenon in Parkinson\u2019s disease patients. Mov Disord Clin Pract 7:273\u2013278","journal-title":"Mov Disord Clin Pract"},{"key":"1444_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fneur.2018.00500","volume":"9","author":"S Heinzel","year":"2018","unstructured":"Heinzel\u00a0S, Berg\u00a0D, Binder\u00a0S et\u00a0al (2018) Do we need to rethink the epidemiology and healthcare utilization of parkinson\u2019s disease in Germany? Front Neurol 9:500","journal-title":"Front Neurol"},{"key":"1444_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger\u00a0GU, Respondek\u00a0G, Stamelou\u00a0M et\u00a0al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00391-020-01734-1","volume":"53","author":"AH Jacobs","year":"2020","unstructured":"Jacobs\u00a0AH, Emmert\u00a0K, Baron\u00a0R et\u00a0al (2020) Neurogeriatrics\u2014a vision for improved care and research for geriatric patients with predominating neurological disabilities. Z\u00a0Gerontol Geriatr 53:340\u2013346","journal-title":"Z Gerontol Geriatr"},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger\u00a0KA (2018) Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J\u00a0Neural Transm 125:615\u2013650","journal-title":"J Neural Transm"},{"issue":"7","key":"1444_CR16","first-page":"2272","volume":"9","author":"L Kerkemeyer","year":"2020","unstructured":"Kerkemeyer\u00a0L, Achtert\u00a0K, Claus\u00a0I et al (2020) Quickcard-based approach to guiding specific nonpharmacological treatments in a\u00a0German Parkinson\u2019s network. J\u00a0Clin Med 9(7):2272","journal-title":"J\u00a0Clin Med"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3233\/JPD-213072","volume":"12","author":"L Kerkemeyer","year":"2022","unstructured":"Kerkemeyer\u00a0L, Claus\u00a0I, Kutscher\u00a0M et al (2022) Strengthening communication and collaboration in the fragmented German healthcare system: a mixed-method evaluation of an interdisciplinary network for parkinson\u2019s disease. J\u00a0Parkinsons Dis 12:1307\u20131317","journal-title":"J Parkinsons Dis"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/mds.27882","volume":"35","author":"HJ Kim","year":"2020","unstructured":"Kim\u00a0HJ, Mason\u00a0S, Foltynie\u00a0T et al (2020) Motor complications in Parkinson\u2019s disease: 13\u2013year follow-up of the CamPaIGN cohort. Mov Disord 35:185\u2013190","journal-title":"Mov Disord"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41582-020-00426-z","volume":"17","author":"JK Krauss","year":"2021","unstructured":"Krauss\u00a0JK, Lipsman\u00a0N, Aziz\u00a0T et\u00a0al (2021) Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol 17:75\u201387","journal-title":"Nat Rev Neurol"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2020.05.002","volume":"75","author":"B Labeit","year":"2020","unstructured":"Labeit\u00a0B, Claus\u00a0I, Muhle\u00a0P et\u00a0al (2020) Oropharyngeal freezing and its relation to dysphagia\u2014An analogy to freezing of gait. Parkinsonism Relat Disord 75:1\u20136","journal-title":"Parkinsonism Relat Disord"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/ene.14603","volume":"28","author":"B Labeit","year":"2021","unstructured":"Labeit\u00a0B, Claus\u00a0I, Muhle\u00a0P et al (2021) Effect of cognitive and motor dual-task on oropharyngeal swallowing in Parkinson\u2019s disease. Eur J Neurol 28:754\u2013762","journal-title":"Eur J Neurol"},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(18)30405-8","volume":"18","author":"PA Lewitt","year":"2019","unstructured":"Lewitt\u00a0PA, Hauser\u00a0RA, Pahwa\u00a0R et al (2019) Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson\u2019s disease: a\u00a0randomised, double-blind, placebo-controlled phase 3 trial. Lancet Neurol 18:145\u2013154","journal-title":"Lancet Neurol"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus\u00a0J, Zhu\u00a0K, Marras\u00a0C et al (2018) Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol 17:559\u2013568","journal-title":"Lancet Neurol"},{"key":"1444_CR24","doi-asserted-by":"publisher","first-page":"175628642211080","DOI":"10.1177\/17562864221108018","volume":"15","author":"D Nyholm","year":"2022","unstructured":"Nyholm\u00a0D, Jost\u00a0WH (2022) Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: real-world experience and practical guidance. Ther Adv Neurol Disord 15:17562864221108018","journal-title":"Ther Adv Neurol Disord"},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe\u00a0W, Seppi\u00a0K, Tanner\u00a0CM et\u00a0al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013","journal-title":"Nat Rev Dis Primers"},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma\u00a0RB, Berg\u00a0D, Stern\u00a0M et\u00a0al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"issue":"5","key":"1444_CR27","first-page":"1455","volume":"9","author":"T Prell","year":"2020","unstructured":"Prell\u00a0T, Siebecker\u00a0F, Lorrain\u00a0M et al (2020) Recommendations for standards of network care for patients with Parkinson\u2019s disease in Germany. J\u00a0Clin Med 9(5):1455","journal-title":"J\u00a0Clin Med"},{"key":"1444_CR28","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/mds.28097","volume":"35","author":"R Rajan","year":"2020","unstructured":"Rajan\u00a0R, Brennan\u00a0L, Bloem\u00a0BR et al (2020) Integrated care in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 35:1509\u20131531","journal-title":"Mov Disord"},{"key":"1444_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1055\/s-0039-1678579","volume":"39","author":"M Sezgin","year":"2019","unstructured":"Sezgin\u00a0M, Bilgic\u00a0B, Tinaz\u00a0S et\u00a0al (2019) Parkinson\u2019s disease dementia and Lewy body disease. Semin Neurol 39:274\u2013282","journal-title":"Semin Neurol"},{"key":"1444_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/mds.24051","volume":"27","author":"MB Stern","year":"2012","unstructured":"Stern\u00a0MB, Lang\u00a0A, Poewe\u00a0W (2012) Toward a\u00a0redefinition of Parkinson\u2019s disease. Mov Disord 27:54\u201360","journal-title":"Mov Disord"},{"key":"1444_CR31","doi-asserted-by":"crossref","unstructured":"Suttrup I, Suttrup J, Suntrup-Krueger S et al (2017) Esophageal dysfunction in different stages of Parkinson\u2019s disease. Neurogastroenterol Motil 29(1)","DOI":"10.1111\/nmo.12915"},{"key":"1444_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00455-015-9671-9","volume":"31","author":"I Suttrup","year":"2016","unstructured":"Suttrup\u00a0I, Warnecke\u00a0T (2016) Dysphagia in Parkinson\u2019s disease. Dysphagia 31:24\u201332","journal-title":"Dysphagia"},{"issue":"9","key":"1444_CR33","first-page":"2743","volume":"9","author":"M Van Munster","year":"2020","unstructured":"Van Munster\u00a0M, Tonges\u00a0L, Loewenbruck\u00a0KF et al (2020) Building a\u00a0parkinson-network-experiences from Germany. J\u00a0Clin Med 9(9):2743","journal-title":"J\u00a0Clin Med"},{"key":"1444_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","volume":"8","author":"T Warnecke","year":"2022","unstructured":"Warnecke\u00a0T, Schafer\u00a0KH, Claus\u00a0I et\u00a0al (2022) Gastrointestinal involvement in Parkinson\u2019s disease: pathophysiology, diagnosis, and management. NPJ Park Dis 8:31","journal-title":"NPJ Park Dis"},{"key":"1444_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning\u00a0GK, Stankovic\u00a0I, Vignatelli\u00a0L et\u00a0al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148","journal-title":"Mov Disord"},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1474-4422(17)30406-4","volume":"17","author":"JHL Ypinga","year":"2018","unstructured":"Ypinga\u00a0JHL, De Vries\u00a0NM, Boonen\u00a0L et\u00a0al (2018) Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a\u00a0retrospective analysis of medical claims data. Lancet Neurol 17:153\u2013161","journal-title":"Lancet Neurol"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01444-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01444-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01444-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T08:05:11Z","timestamp":1675325111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01444-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01444-3","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"assertion":[{"value":"8 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Warnecke hat Honorare erhalten von AbbVie, UCB, Archimedes, Phagenesis, Zambon, Bial und Kyowa f\u00fcr Beratert\u00e4tigkeiten und von Bial, Britannia, AbbVie, STADA, UCB, Biogen, Licher, Desitin, Pfizer, Zambon, Teva und Bayer f\u00fcr Vortragst\u00e4tigkeiten. C.\u00a0Lummer, J.W.\u00a0Rey, I.\u00a0Claus und D.\u00a0L\u00fcttje geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}